Eli Lilly & Co. (LLY)

1149.36 -10.24 (-0.88%) USD  |  NYSE  |  Sep 04, 16:00
1146.66 -2.70 (-0.23%) After-Hours: 20:00
More

Eli Lilly SG&A Expense (TTM) : 12.24B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 12.24B
March 31, 2026 11.56B
December 31, 2025 11.09B
September 30, 2025 10.39B
June 30, 2025 9.746B
March 31, 2025 9.110B
December 31, 2024 8.594B
September 30, 2024 8.094B
June 30, 2024 7.798B
March 31, 2024 7.606B
December 31, 2023 7.403B
September 30, 2023 7.122B
June 30, 2023 6.932B
March 31, 2023 6.632B
December 31, 2022 6.440B
September 30, 2022 6.389B
June 30, 2022 6.353B
March 31, 2022 6.414B
December 31, 2021 6.432B
September 30, 2021 6.394B
June 30, 2021 6.385B
March 31, 2021 6.148B
December 31, 2020 6.121B
September 30, 2020 6.265B
June 30, 2020 6.109B
Date Value
March 31, 2020 6.246B
December 31, 2019 6.214B
September 30, 2019 6.209B
June 30, 2019 6.254B
March 31, 2019 6.154B
December 31, 2018 5.975B
September 30, 2018 6.062B
June 30, 2018 6.160B
March 31, 2018 6.382B
December 31, 2017 6.588B
September 30, 2017 6.598B
June 30, 2017 6.608B
March 31, 2017 6.523B
December 31, 2016 6.452B
September 30, 2016 6.460B
June 30, 2016 6.471B
March 31, 2016 6.483B
December 31, 2015 6.533B
September 30, 2015 6.534B
June 30, 2015 6.631B
March 31, 2015 6.659B
December 31, 2014 6.621B
September 30, 2014 6.774B
June 30, 2014 6.755B
March 31, 2014 6.958B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Johnson & Johnson 25.14B
Merck & Co., Inc. 11.14B
Pfizer Inc. 13.72B
Bristol Myers Squibb Co. 7.413B
Atai Beckley, Inc. 71.80M